Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Dianthus Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 96 | 1 | 99 | +4 |
| Shares | 35.1M | 65.9K | 37.7M | +2.65M (+7.6%) |
| Value | $765.7M | $1.44M | $685.5M | −$78.8M (−10.3%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Deep Track Capital, LP | 2,357,702 | $42.8M | 1.38% |
| Candriam Luxembourg S.C.A. | 248,610 | $4.51M | 0.03% |
| Silverarc Capital Management, LLC | 190,334 | $3.45M | 0.72% |
| Sio Capital Management, LLC | 116,997 | $2.12M | 0.64% |
| Hudson Bay Capital Management LP | 75,000 | $1.36M | 0.01% |
| Moody Aldrich Partners LLC | 74,372 | $1.35M | 0.28% |
| Nuveen, LLC | 64,381 | $1.17M | 0.00% |
| HRT Financial LP | 10,997 | $199.0K | 0.00% |
| Virtus Investment Advisers, Inc. | 6,986 | $126.7K | 0.03% |
| Picton Mahoney Asset Management | 455 | $8.00K | 0.00% |
| Simplex Trading, LLC | 111 | $2.00K | 0.00% |
| Allworth Financial LP | 27 | $574 | 0.00% |
| TD Private Client Wealth LLC | 17 | $308 | 0.00% |
| EverSource Wealth Advisors, LLC | 13 | $236 | 0.00% |
| CoreCap Advisors, LLC | 11 | $200 | 0.00% |
| Creative Financial Designs Inc | 10 | $181 | 0.00% |
Sold out (12)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| RTW Investments, LP | 666,667 | $14.5M |
| Millennium Management LLC | 90,436 | $1.97M |
| Allostery Investments LP | 25,000 | $545.0K |
| Swiss National Bank | 14,400 | $313.9K |
| Two Sigma Investments, LP | 10,601 | $231.1K |
| Quest Partners LLC | 4,197 | $91.5K |
| Virtus ETF Advisers LLC | 3,025 | $65.9K |
| KBC Group NV | 1,593 | $35.0K |
| KLP Kapitalforvaltning AS | 1,500 | $32.7K |
| R Squared Ltd | 1,200 | $26.2K |
| Lindbrook Capital, LLC | 21 | $458 |
| Caitong International Asset Management Co., Ltd | 13 | $283 |
Not filed for Q1 2025 yet (1)
Institutions that held Dianthus Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 65,851 | $1.44M |